Luo Y - Search Results

1

Multifunctional hybrid sponge for in situ postoperative management to inhibit tumor recurrence.

Wang H, Jin Y, Chen Y, Luo Y, Lv S, Li M, Tao Y. Wang H, et al. Among authors: luo y. Biomater Sci. 2021 Jun 4;9(11):4066-4075. doi: 10.1039/d1bm00085c. Biomater Sci. 2021. PMID: 33908452

2

Nanomedicine to advance the treatment of bacteria-induced acute lung injury.

Su R, Zhang Y, Zhang J, Wang H, Luo Y, Chan HF, Tao Y, Chen Z, Li M. Su R, et al. Among authors: luo y. J Mater Chem B. 2021 Nov 17;9(44):9100-9115. doi: 10.1039/d1tb01770e. J Mater Chem B. 2021. PMID: 34672317 Review.

3

Recent advances in nanomaterials for prostate cancer detection and diagnosis.

Hu Y, Lv S, Wan J, Zheng C, Shao D, Wang H, Tao Y, Li M, Luo Y. Hu Y, et al. Among authors: luo y. J Mater Chem B. 2022 Jul 6;10(26):4907-4934. doi: 10.1039/d2tb00448h. J Mater Chem B. 2022. PMID: 35712990 Review.

4

Self-intensified synergy of a versatile biomimetic nanozyme and doxorubicin on electrospun fibers to inhibit postsurgical tumor recurrence and metastasis.

Hu Y, Xu Y, Mintz RL, Luo X, Fang Y, Lao YH, Chan HF, Li K, Lv S, Chen G, Tao Y, Luo Y, Li M. Hu Y, et al. Among authors: luo x, luo y. Biomaterials. 2023 Feb;293:121942. doi: 10.1016/j.biomaterials.2022.121942. Epub 2022 Dec 5. Biomaterials. 2023. PMID: 36512863

5

Effects of probiotic supplementation on serum trimethylamine-N-oxide level and gut microbiota composition in young males: a double-blinded randomized controlled trial.

Chen S, Jiang PP, Yu D, Liao GC, Wu SL, Fang AP, Chen PY, Wang XY, Luo Y, Long JA, Zhong RH, Liu ZY, Li CL, Zhang DM, Zhu HL. Chen S, et al. Among authors: luo y. Eur J Nutr. 2021 Mar;60(2):747-758. doi: 10.1007/s00394-020-02278-1. Epub 2020 May 21. Eur J Nutr. 2021. PMID: 32440731 Clinical Trial.

6

Betaine Delayed Muscle Loss by Attenuating Samtor Complex Inhibition for mTORC1 Signaling Via Increasing SAM Level.

Chen S, Lu XT, He TT, Yishake D, Tan XY, Hou MJ, Luo Y, Long JA, Tang ZH, Zhong RH, Fang AP, Zhu HL. Chen S, et al. Among authors: luo y. Mol Nutr Food Res. 2021 Aug;65(15):e2100157. doi: 10.1002/mnfr.202100157. Epub 2021 Jun 25. Mol Nutr Food Res. 2021. PMID: 34061446

7

Harnessing machine learning and multi-omics to explore tumor evolutionary characteristics and the role of AMOTL1 in prostate cancer.

Zhu W, Wu J, Lai W, Li F, Zeng H, Li X, Su H, Liu B, Zhao X, Zou C, Xiao H, Luo Y. Zhu W, et al. Among authors: luo y. Int J Biol Macromol. 2024 Dec 4;286:138402. doi: 10.1016/j.ijbiomac.2024.138402. Online ahead of print. Int J Biol Macromol. 2024. PMID: 39643184

8

High CD204⁺ tumor-associated macrophage density predicts a poor prognosis in patients with clear cell renal cell carcinoma.

Xie Y, Tang G, Xie P, Zhao X, Chen C, Li X, Zhang Y, Wang B, Luo Y. Xie Y, et al. Among authors: luo y. J Cancer. 2024 Jan 21;15(6):1511-1522. doi: 10.7150/jca.91928. eCollection 2024. J Cancer. 2024. PMID: 38370385 Free PMC article.

9

Measurements of peri-prostatic adipose tissue by MRI predict bone metastasis in patients with newly diagnosed prostate cancer.

Liu BH, Mao YH, Li XY, Luo RX, Zhu WA, Su HB, Zeng HD, Chen CH, Zhao X, Zou C, Luo Y. Liu BH, et al. Among authors: luo y, luo rx. Front Oncol. 2024 Apr 26;14:1393650. doi: 10.3389/fonc.2024.1393650. eCollection 2024. Front Oncol. 2024. PMID: 38737904 Free PMC article.

10

Autophagy-Related Long Non-coding RNA Is a Prognostic Indicator for Bladder Cancer.

Wan J, Guo C, Fang H, Xu Z, Hu Y, Luo Y. Wan J, et al. Among authors: luo y. Front Oncol. 2021 Apr 1;11:647236. doi: 10.3389/fonc.2021.647236. eCollection 2021. Front Oncol. 2021. PMID: 33869042 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,410 results

Search Page

Filters